会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Method and apparatus for enhancing link range in a wireless network using a self-configurable antenna
    • 使用自配置天线增强无线网络中的链路范围的方法和装置
    • US08483762B2
    • 2013-07-09
    • US12207593
    • 2008-09-10
    • David SteerKoon Hoo TeoAdrian Smith
    • David SteerKoon Hoo TeoAdrian Smith
    • H04M1/00H04B1/06
    • H01Q3/2611H01Q3/26
    • Embodiments of the invention facilitate providing wireless links with longer link ranges and/or better suppression of interference than can be provided by the integrated antennas of a typical wireless network node. While, in some cases, it is possible to install intermediate wireless network nodes to hop through long expanses between distant wireless network nodes, it is desirable for distantly spaced wireless network nodes to reach one another through a single transit link (i.e. one hop). This approach is preferable because a single transit link is capable of higher data rates and better interference suppression than multi-hop transit links. The present invention provides methods and apparatus for enhancing the link range achievable by typical wireless network nodes so that distantly spaced wireless network nodes are able to communicate with one another using only a single-transit link.
    • 本发明的实施例有助于提供具有比典型无线网络节点的集成天线提供的更长的链路范围和/或更好的干扰抑制的无线链路。 虽然在某些情况下,有可能安装中间无线网络节点来跳过远距离无线网络节点之间的长时间扩展,但是期望远距离间隔的无线网络节点通过单个转接链路(即,一跳)彼此到达。 这种方法是优选的,因为单个转接链路能够具有比多跳中继链路更高的数据速率和更好的干扰抑制。 本发明提供了用于增强典型无线网络节点可实现的链路范围的方法和装置,使得远距离间隔的无线网络节点能够仅使用单一转接链路彼此通信。
    • 5. 发明授权
    • Minimization of radio resource usage in multi-hop networks with multiple routings
    • 在具有多个路由的多跳网络中最小化无线资源使用
    • US08149707B2
    • 2012-04-03
    • US10683182
    • 2003-10-10
    • David SteerKoon Hoo TeoAdrian Smith
    • David SteerKoon Hoo TeoAdrian Smith
    • G06F11/00
    • H04W40/246H04L45/12H04L45/121H04L45/36H04W28/08H04W40/28H04W84/22
    • Packets in a multi-hop wireless network are routed based on the available link throughputs, network node congestion and the connectivity of the network in a manner that minimizes the use of radio resources and minimizes delay for packets in multi-hop system. The routing method also avoids congestion in the access network, especially near the network access points as provided by network access nodes. Each wireless network node maintains a link table for storing link conditions and associated route costs. Packets are routed according to the low cost route. Subsequent wireless network nodes evaluate whether a lower cost route is available and, if so, route the data packet according to the lower cost route. Every wireless network node transmits the data packet, a specified route and a time stamp indicated a time of the last data entry in the link table that was used to calculate the low cost route.
    • 基于可用的链路吞吐量,网络节点拥塞和网络的连通性,以最小化无线资源的使用并最小化多跳系统中的分组的延迟的方式来路由多跳无线网络中的分组。 路由方法还可以避免接入网络中的拥塞,特别是网络接入节点附近的网络接入点。 每个无线网络节点维护用于存储链路条件和相关联的路由成本的链路表。 数据包根据低成本路由进行路由。 随后的无线网络节点评估较低成本路由是否可用,如果是,则根据较低成本路由路由数据分组。 每个无线网络节点发送数据包,指定的路由和时间戳表示在用于计算低成本路由的链路表中最后一个数据条目的时间。
    • 9. 发明申请
    • Method
    • 方法
    • US20100279317A1
    • 2010-11-04
    • US12745862
    • 2007-12-03
    • Adrian Smith
    • Adrian Smith
    • G01N33/53C12Q1/02C07K7/08
    • C07K14/7051G01N33/505G01N2333/7051
    • The present invention provides a method for identifying a single or group of T cell receptors (TCR) protective and/or effective against a disease, having the following steps: i) obtaining T cells from a donor non-human animal; ii) adoptive transfer of the T cells into a plurality of T cell-deficient recipient non-human animals in a number such that at least one recipient animal is protected against the disease but at least one animal remains unprotected; and iii) determination of the TCR(s) present only in the protected animals. These TCR can be used to identify the determinants or antigens for inclusion in a vaccine or other treatment.
    • 本发明提供了用于鉴定对疾病有保护和/或有效的单个或一组T细胞受体(TCR)的方法,其具有以下步骤:i)从供体非人动物获得T细胞; ii)将T细胞过继转移到多个T细胞缺陷型受体非人动物中,使得至少一种受体动物被保护免受疾病,但至少一种动物保持不受保护; 和iii)确定仅在受保护的动物中存在的TCR。 这些TCR可用于鉴定包含在疫苗或其他治疗中的决定簇或抗原。